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Abstract
Background: Eukaryotic cells contain numerous compartments, which have different protein
constituents. Proteins are typically directed to compartments by short peptide sequences that act
as targeting signals. Translocation to the proper compartment allows a protein to form the
necessary interactions with its partners and take part in biological networks such as signalling and
metabolic pathways. If a protein is not transported to the correct intracellular compartment either
the reaction performed or information carried by the protein does not reach the proper site,
causing either inactivation of central reactions or misregulation of signalling cascades, or the
mislocalized active protein has harmful effects by acting in the wrong place.
Results: Numerous methods have been developed to predict protein subcellular localization with
quite high accuracy. We applied bioinformatics methods to investigate the effects of known disease-
related mutations on protein targeting and localization by analyzing over 22,000 missense
mutations in more than 1,500 proteins with two complementary prediction approaches. Several
hundred putative localization affecting mutations were identified and investigated statistically.
Conclusion: Although alterations to localization signals are rare, these effects should be taken into
account when analyzing the consequences of disease-related mutations.
Background
Eukaryotic cells contain numerous compartments, such as
cytoplasm, mitochondria, Golgi apparatus, and peroxi-
somes, all of which contain different protein constituents
and have different functions. Proteins are typically
directed to these compartments by short peptide
sequences that act as targeting signals. For example, secre-
tory, chloroplast and mitochondrial targeting peptides are
located at the N terminus, whereas signals for other com-
partments can be within the amino acid sequence. Termi-
nal signal peptides are typically cleaved during the protein
translocation process.
Protein function depends on numerous factors. One
important but often neglected property is its subcellular
localization. Translocation to the proper compartment
allows a protein to form the necessary interactions with its
partners and take part in biological networks. For exam-
ple, signalling and metabolic pathways are dependent on
the location of the constituent proteins. Failure to be
transported to the correct intracellular compartment can
have detrimental effects, which appear in different ways.
Either the reaction performed or information carried by
the protein does not reach the proper site, causing either
inactivation of central reactions or misregulation of, eg,
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signalling cascades, or the mislocalized protein is active,
but has harmful effects by acting in the wrong place.
Subcellular localization of proteins and peptides has long
been investigated using numerous methods. Recently,
high-throughput methods have been developed based
either on the use of reporter genes/tags or by purification,
fractionation and analysis of cellular compartments [1,2].
Information on protein localization is scattered through-
out publications and numerous databases. Fortunately,
central resources such as the Human Protein Reference
Database (HPRD) [3], UniProt [4] and Gene Ontologies
[5] now exist to integrate information from several
sources. A problem with these databases, however, is that
data quality and experimental methods vary. Further,
some databases contain experimentally validated localiza-
tion information whereas others also contain localization
predictions. The picture is further complicated by the fact
that a protein can be localized in more than one compart-
ment, often depending on the state of the cell. Thus, data-
bases that contain only experimentally validated data may
not provide complete information for all proteins.
Numerous methods have been developed to predict pro-
tein subcellular localization (for review, see eg, [6]). The
very first methods in the 1970's were developed to iden-
tify microbial signal peptides [7,8]. Now, methods and
protocols exist for the prediction of over 10 cellular com-
partments and subcompartments. Although the actual
prediction algorithms and methods differ, all are based on
sequence signature patterns. Some general predictors are
useful for all subcompartments, but the majority of meth-
ods are specific for individual compartments and organ-
isms or groups of organisms. The reliability of individual
methods is relatively high, close to 90% (see, eg, [9-11])
Disease-causing mutations result in abnormal cellular
function through numerous mechanisms. To date, patho-
logical mechanisms have been revealed for only a fraction
of all known mutations. Mutation information has been
collected and stored in locus-specific (eg, [12,13]) and
general (such as Online Mendelian Inheritance in Man
(OMIM) and Human Gene Mutation Database (HGMD))
databases. Many experimental methods are tedious,
expensive and difficult to use. Disease-causing mutations
are identified for diagnostic purposes, and thus most
medical centers identify a genetic mutation(s) without
acquiring further information about the protein. We and
others have applied numerous bioinformatic methods to
predict and explain the consequences of mutations.
Recently, we discussed the applicability of some 40 analy-
sis and prediction methods [14,15]. The effects and con-
sequences vary depending on the site and type of
mutation, with insertions and deletions usually leading to
truncated proteins. These cases are easy to explain if a sub-
stantial part of the protein is missing. To understand pro-
tein structure and function, however, missense mutations
are most interesting because they often indicate residues
that are critical for, and changes that are deleterious to,
structure and/or function. Most mutations reduce protein
activity, but increasing numbers of gain-of-function muta-
tions [16,17] are also being identified. Relatively few
detailed investigations have described protein mislocali-
zation due to disease-related mutations or introduced
genetic alterations. In addition, all such publications
report a limited number of mutations in a single protein.
Targeting signals tend to be conserved and thus sensitive
to alterations; therefore, we can assume that these meth-
ods can be applied to the analysis of point mutations.
Here we use bioinformatics to investigate the effects of
known disease-related mutations on protein targeting and
localization by analyzing 22,416 missense mutations.
Several hundred putative localization mutations were
identified with two complementary multiprediction
approaches. The results indicate that although alterations
to localization signals are rare, localization predictors
should be added to the methods arsenal of a mutations
analyst. Our results also suggest pathological mechanisms
for a number of mutations and depict cases for further
experimental investigation.
Results and discussion
We investigated the effects of disease-related mutations on
protein localization by performing large-scale analysis
and prediction with two different but complementary
methods. Because we needed unambiguous mapping of
DNA mutations to protein sequences, we performed filter-
ing steps. We obtained experimentally identified protein
localizations from HPRD [3], which is considered a highly
accurate, consistent and reliable source of protein annota-
tions.
Reliability of the individual localization predictors
Before approaching the mutation effect predictions, we
wanted to test the applicability of the methods to the data-
set. Because HPRD contains experimentally verified data,
we compared the localizations to predictions for the wild
type proteins. The analysis was made for localizations for
which SP and/or WoLF PSORT make predictions.
The compartments with the largest numbers of proteins
are plasma membrane, cytoplasm, nucleus, extracellular
space, and mitochondria (see Additional file 1). Endo-
plasmic reticulum (ER) had the highest number of pro-
teins as a secondary classification (see Additional file 2).
Proteins were distributed unequally among the different
compartments. Although disease-related proteins form a
special group, they still reflect the overall properties of all
proteins.BMC Genomics 2009, 10:122 http://www.biomedcentral.com/1471-2164/10/122
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Table 1 indicates that results for TMHMM, TargetP predic-
tions for mitochondrial proteins, PeroxiP and PTS1 have
high accuracy while Golgipredictor and PredictNLS have
only moderate performance. Precision values indicate
that except for Golgipredictor and PeroxiP the predictors
mainly detect the proteins well. However, when recall is
considered, only TargetP and TMHMM are highly reliable.
The overall parameter MCC values range from 0.056 to
0.58.
One reason for the poor behaviour of certain predictors is
likely the fact that they are usually not used alone i.e.
other programs are used to sort the data to localization
routes before applying these tools. Overall, the methods
obtained good precision at the cost of recall (false nega-
tives). In summary, the individual methods can be
applied with relatively high accuracy and precision to
localization predictions. Methods, which predict the
localization at the end of a complex pathway, are less reli-
able when applied directly to sequences.
Reliability of the combined localization predictors
The SP predicted localization for 12 possible compart-
ments and WoLF PSORT (animal version) predicted ten
localizations. The results for the two approaches and com-
parison to experimental data for the wild type proteins are
shown in Tables 2 and 3. Several parameters were calcu-
lated to describe the prediction performance. For the SP,
altogether 60.9% (966/1586) of predictions were correct.
Seventy proteins received two predictions in TargetP and
thus two routes in SignalP. In these cases both predictions
are included. No mitochondrial periplasmic space pro-
teins were predicted and the false negative rate is very high
for these cases. The precision and recall of Golgi, trans-
membrane is low as well as the values for peroxisomal
localization. Accuracy and precision are usually clearly
better than the recall values, which is in line with the
results for individual predictors (Table 1). The results for
gPM and mPM were combined to those for plasma mem-
brane, since these localizations were predicted only for 3
and 6 proteins, respectively.
In the case of WoLF PSORT, 33.7% (1696/5095) gave cor-
rect predictions (Table 3). There are a number of dual pre-
dictions, eg for proteins, which shuttle between cytosol
and nucleus. Results for these predictions were considered
as correct only if the protein was found from both com-
partments. Values for accuracy ranged from 0.69 to 0.98
(average 0.854), whereas recall ranged from 0 to 0.84
(average 0.375). Peroxisomal proteins clearly had the
lowest prediction accuracy. The results for WoLF PSORT
do not allow a direct comparison with the SP, because
WoLF PSORT considers combined predictions to be cor-
rect when one of the predictions is correct. Actually, just
six classes had a substantial number of predicted proteins.
The overall accuracy is almost identical for the two proto-
cols whereas SP has clearly better precision and somewhat
higher MCC score. The recall is slightly better for WoLF
PSORT.
In conclusion, detailed analysis of the prediction perform-
ance indicates that the subcellular localization predictors
still have much to improve. However, because the accu-
racy of individual predictions are rather high, these meth-
ods are indeed applicable to systematic analysis of
mutations even though the precision, recall and MCC are
clearly suboptimal. The more steps there are in the analy-
sis the lower the expected accuracy (and other parameter
values). Thus, if the analysis is based on five consecutive
steps (as in SP) in which each step has 90% accuracy the
final expected accuracy would be 59% (0.95).
Analysis of mutation effects
As the results above indicate, the subcellular localization
of individual compartments of the investigated proteins
can be predicted with rather high accuracy and also mul-
tipredictors provide useful data. The effect of mutations
on protein localization was tested for all 22,416 missense
mutations. In this analysis we looked for differences in
predicted localization compared with that for wild type
forms. Even if the prediction of the compartment was
incorrect, a change in the predicted localization due to
mutation might indicate the mutation mechanism and be
Table 1: Prediction results for the localization of wild type proteins with the individual predictorsa
Compartment tp rp tn fn Accuracy Precision Recall MCC Proteins located
TargetP (mitochodrial) 101 109 1254 52 0.894 0.481 0.660 0.506 210
TMHMM 377 144 853 142 0.811 0.724 0.726 0.581 521
Golgipredictor 23 178 227 20 0.558 0.114 0.535 0.056 201
PeroxiP 6 24 423 12 0.923 0.200 0.333 0.220 30
PTS1 3 1 446 15 0.966 0.750 0.167 0.343 4
PredictNLS 98 23 248 217 0.590 0.810 0.311 0.279 121
Summary 0.790b 0.513b 0.455b 0.331b 1087
atp, the number of positive cases that were correctly predicted; tn, the number of negative cases correctly predicted; fp, the number of positive 
cases incorrectly predicted; fn, the number of negative cases incorrectly predicted.
baverage value.BMC Genomics 2009, 10:122 http://www.biomedcentral.com/1471-2164/10/122
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Table 2: Prediction results for the localization of wild type proteins with the Scandinavian protocol.
Compartmenta tp fp tn fn Accuracy Precision Recall MCC Proteins located
Mtm 10 29 1337 140 0.889 0.256 0.067 0.086 39
Mps 0 6 1363 147 0.899 0.000 0.000 -0.021 6
Mma 91 74 1293 58 0.913 0.552 0.611 0.532 165
Gtm 23 178 1240 75 0.833 0.114 0.235 0.079 201
PM 221 35 619 641 0.554 0.863 0.256 0.268 256
S 246 84 1093 93 0.883 0.745 0.726 0.661 330
ER 2 1 1330 183 0.879 0.667 0.011 0.074 3
N 98 23 1097 298 0.788 0.810 0.247 0.368 121
P 6 24 1462 24 0.968 0.200 0.200 0.184 30
C 269 166 852 229 0.739 0.618 0.540 0.392 435
Summary 966b 620b 1888b 0.835c 0.483c 0.289c 0.262c 1586b
Abbreviations for statistical parameters as in Table 1.
a C, cytosol; Gtm, Golgi, transmembrane; Mma, mitochondrial matrix; Mps, mitochondrial, periplasmic space; Mtm, mitochondrial transmembrane; 
N, nuclear; P, peroxisomal; PM, plasma membrane; S, secreted
btotal number
caverage value.
Table 3: Prediction results for the localization of wild type proteins with WoLF PSORT.
Mutant compartment
Wild type compartmenta tp fp tn fn Accuracy Precision Recall MCC Proteins located
CK 2 38 1471 5 0.972 0.050 0.286 0.110 40
CK_PM 0 31 1485 31 0.960 0.000 0.000 -0.020 31
C 339 304 713 160 0.694 0.527 0.679 0.362 643
C_G 0 29 1450 37 0.956 0.000 0.000 -0.022 29
C_M 8 145 1328 35 0.881 0.052 0.186 0.048 153
C_N 102 365 963 86 0.703 0.218 0.543 0.191 467
C_P 3 77 1425 11 0.942 0.038 0.214 0.070 80
ER 85 253 1081 97 0.769 0.251 0.467 0.217 338
ER_G 4 70 1392 50 0.921 0.054 0.074 0.023 74
ER_M 2 92 1413 9 0.933 0.021 0.182 0.042 94
S 281 321 856 58 0.750 0.467 0.829 0.474 602
S_PM 4 148 1358 6 0.898 0.026 0.400 0.081 152
G 13 74 1344 85 0.895 0.149 0.133 0.085 87
L 33 202 1258 23 0.852 0.140 0.589 0.235 235
M 128 325 1038 25 0.769 0.283 0.837 0.394 453
M_N 0 33 1459 24 0.962 0.000 0.000 -0.019 33
M_P 1 112 1397 6 0.922 0.009 0.143 0.018 113
N 325 330 790 71 0.735 0.496 0.821 0.467 655
P 12 302 1184 18 0.789 0.038 0.400 0.068 314
PM 356 185 841 134 0.790 0.658 0.727 0.533 542
Summary 1696b 3398b 966b 0.854c 0.174c 0.375c 0.168c 5095b
Abbreviations for statistical parameters as in Table 1.
aC, cytosol; CK, cytoskeleton; G, Golgi compartment; M, mitochondrial; N, nuclear; P, peroxisomal; PM, plasma membrane; S, secreted
btotal number. Underline sign indicates multiple predictions.
caverage valueB
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Table 4: Changes in SP localization prediction due to mutations.
Mutant compartment
Wild type 
compartmenta
Gtm Mtm/Gtm Mma/C Mma Mma/PM Mps/S C Mma/P N PM Mtm S Mtm/PM Mma/N P Total
Mtm/Gtm 0/3 1/1 1/4
Mtm/PM 0/6 0/9 1/1 1/16
PM 17/47 0/1 4/5 21/53
S0 / 4 7/8 7/12
C 0/1 8/8 19/20 1/1 1/1 0/2 29/33
Mtm 0/3 1/1 1/4
Mma/Gtm 0/2 0/2
Gtm 0/5 17/21 0/1 2/4 19/31
Mtm/C 0/1 1/4 1/5
Mps/C 1/1 1/1
Mma 6/6 1/1 2/2 1/1 10/10
Mma/S 2/2 1/1 1/1 4/4
Mma/C 4/4 4/4
Mps 2/2 2/2
Mma/N 1/1 1/1 2/2
P 1/1 1/1
N 0/18 1/1 1/19
Total 17/61 0/19 17/18 3/6 2/2 4/4 7/8 1/1 21/22 25/48 0/1 3/5 4/5 1/1 0/2 105/203
The numbers separated by the slash sign are for how many proteins the wild type localization has been correctly predicted, and the number of analyzed mutations, respectively.
aC, cytosol; Gtm, Golgi, transmembrane; Mma, mitochondrial matrix; Mps, mitochondrial, periplasmic space; Mtm, mitochondrial transmembrane; N, nuclear; P, peroxisomal; PM, plasma membrane; S, 
secreted. Slash sign indicates alternative predicted localizations.B
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Table 5: Changes in WoLF PSORT localization prediction due to mutations.
Mutant compartment
Wild type compartmenta PM S S_PM C C_N C_M N N/C_N N/C/C_N ER ER_M M M_N M_N/C_M P L CK Total
P 2/2 0/1 1/6 2/2 0/1 0/6 1/1 6/19
S 0/1 0/4 0/1 4/5 1/1 4/9 0/2 9/23
S/S_PM 0/1 0/1
C 0/6 2/3 3/9 3/3 5/6 0/1 3/6 2/2 18/36
C/C_N 1/1 1/1
C_N 0/2 18/19 4/8 2/2 2/2 3/3 29/36
C_M 1/1 1/1
N 0/1 0/10 6/10 7/7 2/4 15/32
G/ER_G 0/1 0/1
ER 0/11 0/1 1/1 0/1 2/2 3/16
M 0/2 3/3 6/6 0/2 0/2 9/15
ER_M 1/1 1/1
M/P/M_P 0/1 0/1
Total 0/21 7/21 0/1 37/53 7/11 3/3 12/20 0/3 0/1 4/7 1/1 11/28 2/2 3/3 3/3 0/3 2/2 92/183
The numbers separated by the slash sign are for how many proteins the wild type localization have been correctly predicted, and the number of analyzed mutations, respectively.
aC, cytosol; CK, cytoskeleton; G, Golgi compartment; M, mitochondrial; N, nuclear; P, peroxisomal; PM, plasma membrane; S, secreted. Slash sign indicates alternative localization predictions and underline 
sign multiple predicted localizations.BMC Genomics 2009, 10:122 http://www.biomedcentral.com/1471-2164/10/122
Page 7 of 14
(page number not for citation purposes)
Amino acid distribution for the two prediction schemes Figure 1
Amino acid distribution for the two prediction schemes. Scandinavian protocol (A, B) and WoLF PSORT (C, D) pre-
dictions of (A, C) amino acids in wild type proteins that are predicted to be mutated in localization mutants, and (B, D) mutant 
amino acids in localization mutants.BMC Genomics 2009, 10:122 http://www.biomedcentral.com/1471-2164/10/122
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useful for further studies. Similar effect has been useful
also in some other bioinformatics predictions such as pro-
tein secondary structures.
The SP predicted that 203 mutations would alter protein
localization. Results in Table 4 and in Additional file 3
show the distribution of mutations in the different sub-
compartments for the mutations and proteins in which
the mutations appear, respectively. The numbers repre-
sent correctly predicted proteins and the total number of
mutations for each category. The most common original
compartments for proteins whose localization changed
on account of the mutation were plasma membrane,
Golgi transmembrane, nucleus, and cytoplasm. Most
common among the mutant sublocalizations were
plasma membrane, Golgi transmembrane, and nucleus.
The single most common predicted mutation type was
from plasma membrane (for wild type localization) to
Golgi transmembrane–altogether 47 cases, 17 of which
had the correct prediction for the wild type form.
Schematic illustration of the analysis of protein localization with the Scandinavian protocol Figure 2
Schematic illustration of the analysis of protein localization with the Scandinavian protocol. The predicted com-
partments are indicated with corresponding numbers in black circles. The localizations are listed in the middle of the figure. 
RC, reliability coefficient; SP, signal peptide; TM, transmembrane region.BMC Genomics 2009, 10:122 http://www.biomedcentral.com/1471-2164/10/122
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Although the number of correct wild type predictions was
not directly related to the mutation predictions, the num-
bers varied widely–as an extreme case C to N prediction,
with 19 of 20 having the correct wild type prediction for
11 proteins out of 12. The range of changes to localiza-
tions of mutations varied from one to five, the highest
being for Gtm proteins. Similarly, the predicted range of
mislocalizations from one subcompartment to others var-
ied from one to six, with cytoplasmic proteins being redi-
rected to six different compartments when mutated.
Results for the mutations and proteins analyzed by WoLF
PSORT are shown in Table 5 and Additional file 4, respec-
tively. To avoid excessive partitioning of the results to very
small groups, only the results for the highest prediction
score are indicated. About 50% of the wild type proteins
had the correct localization. Altogether, WoLF PSORT
found 183 cases with predicted alteration caused by muta-
tion. The highest number of mutation-based rerouting to
other compartments was for proteins whose wild type
form was predicted to localize to the cytoplasm. Extracel-
lular, cytoplasm, plasma membrane, nuclear and mito-
chondria are the most common localizations for mutant
proteins. In comparison to SP, WoLF PSORT had some-
what lower numbers in target compartments. The changes
with the largest number of mutations were CN to C, and
N to C, which are related predictions. WoLF PSORT may
suffer from using BLAST as part of its algorithm. In the
case of SP, the search for homologues was not imple-
mented, however, that was not possible to do for WoLF
PSORT.
The results for the identified changes in protein localiza-
tion due to missense mutations are shown in Additional
file 5 and Additional file 6. The two prediction
approaches, SP and WoLF PSORT, agreed on 17267
(77%) of the total 22,416 mutations when all predictions
of WoLF PSORT were taken into account. Of the two
approaches, 203 and 183 mutations were predicted to
alter the target compartments of mutant proteins, affect-
ing 105 and 92 proteins, respectively. 18 of these proteins
were common for the two methods, and in these proteins
the protocols agreed on 12 mutations to affect proteins
localization. The two methods predicted the same com-
partment mislocalization in seven cases. This indicates
that neither of the methods was able to detect all putative
localization mutations. Similar result calling for use of
several tools was apparent when splice site prediction
tools were tested for mutation analysis [18].
We can estimate the number of expected mutations in
localization sites. Our data set contains 1,516 proteins,
which consist of 1,054,823 amino acid residues, and
which have 2373 localizations based on HPRD. The
length of the targeting peptides varies from a few residues
to close to 30. If we use an average value of eight residues
for the targeting peptide, we should see 403 (2373*8/
1054823*22416) mutations in localization signals. This
number is almost exactly what was observed.
The distribution of the amino acid changes in the pre-
dicted localization alterations is shown in Fig. 1. The
amino acid distributions for mutations were compared
with information for all human proteins taken from
Codon Usage Tabulated from GenBank (CUTG) [19]. The
distribution of all the mutations was significantly biased
compared to random distribution in all amino acid types
except for D and H (see Additional file 7). The results are
in line with previous mutation distribution studies for
numerous proteins and secondary structural elements
within them [20-22], including mutations in the protein
kinase family [23] and in immunodeficiencies [12]. These
studies indicated highly skewed distribution for disease
mutations, which varies also between secondary structural
elements. Data for the SP indicated that mutations are
most common in R (Fig. 2 and Additional file 8). Arginine
is coded by six synonymous codons, four of which con-
tain a CpG dinucleotide, a well known mutational hot
spot [24]. Also G, L and M are frequently mutated. The
most common mutant residues were R, C, and P, of which
arginine is the most common. Arginine was usually
replaced by C (14 of 50 cases), making this the single most
frequent mutation type. Eight of 9 mutations to W were
from R, and 7 of 8 mutations in Q were from arginine.
Arginine was mutated altogether to 10 other residues, i.e.,
all except two (K and M) of the possible substitutions with
single nucleotide changes. Arginine was also the most
common resulting residue from mutations in other
codons, and it was the residue type with the highest
number of original residues, 9. Somewhat surprisingly, no
localization mutations were identified in Q, which how-
ever occurred 8 times as a mutant residue.
Of note, only two mutations to A and three mutations to
F were predicted to be disease-related. H, Q and E were the
least frequently mutated residues. These results follow
somewhat the general amino acid distribution with prom-
inent exceptions like arginine.
WoLF PSORT results show some differences from SP,
which may have originated from the prediction algo-
rithm. R, G, and L were the most commonly mutated res-
idues. However, arginine did not show the clear
overprediction as in the SP data. D, H and K were the least
mutated residues (Fig. 2 and Additional file 9). Mutations
to G and R both appeared in seven original residue types,
whereas S was mutated from eight original residues. These
were also the residues that had the highest number of
mutant residue types. Only one change to H, two to N, D
or I were predicted to be related to diseases.BMC Genomics 2009, 10:122 http://www.biomedcentral.com/1471-2164/10/122
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Comparison to known mislocalization mutations
Our results predicted localization changes that underlie
many different types of diseases, including those involv-
ing signal transduction, metabolism, immunodeficien-
cies, eye diseases, developmental disorders and cancers
(see Additional file 5 and Additional file 6). Some disease-
related mutations, which have been confirmed to affect
protein localization, have been described. These cases are
usually sporadic in the literature. Because no database is
available for such mutations, we performed a literature
search and identified a number of cases.
Mutations in SHOX, homeobox-containing gene, cause
idiopathic short stature, Leri-Well dyschondrosteosis and
Langer mesomelic dysplasia. The substitution R173C pre-
vents the transport of the SHOX-encoded protein to the
nucleus and its subsequent function as a transcription
activator [25]. Both the SP and WoLF PSORT correctly pre-
dicted the mislocalization and the effect of the mutation.
AIRE, autoimmune regulator, is a nuclear protein and
transcriptional regulator. Wild type AIRE appears both in
nuclear dots, as evenly distributed in the nucleus, and in
the cytoplasm. Several mutations have been shown to
affect the distribution of AIRE between compartments
[26-28]. Mutations R14L, T16M, A21V and Y85C were
correctly predicted to affect protein localization by the SP
and L28P and L29P by WoLF PSORT predictor. However,
the predicted changes were not accurate, because the SP
has a change from cytoplasmic and mitochondrial matrix
to cytoplasm and WoLF PSORT from secreted to mito-
chondrial.
Similar results were obtained for BSND mutations. Bar-
ttin, encoded by BSND, is involved in Bartter syndrome, a
renal tubular salt-wasting disease. Barttin localizes to the
plasma membrane, whereas mutant forms are retained in
the ER [29]. R8L was predicted by SP to change the local-
ization from Golgi transmembrane to plasma membrane.
A milder form, G10S, which appears in both the ER and
the plasma membrane, was not predicted to affect locali-
zation. We also consider this kind of prediction useful
because a localization change is forecast due to the muta-
tion. Thus, the predictions can give a hint of the possible
mechanism, even though the final validation must be
obtained experimentally.
We did predictions for cases, which according to liture
affect the localization in ATP7B mutations in Wilson dis-
ease [30], ABCA1  mutations in Scott syndrome [31],
RPS19  mutations in Diamond-Blackfan anemia [32],
ABCA1 mutations in Tangier disease [33], and laminin A/
C mutations in heritable dilated cardiomyopathy [34].
However, the predictions agreed with the experimental
data only for the FXYD2 mutation in hereditary primary
hypomagnesia [35]. These results show the poor recall of
the methods.
Several reasons account for failure of the predictions to
detect all the localization changes. As noted above, the
predictions are characterized by high accuracy and low
recall. Even the experimental information can sometimes
be misleading, because the localization effect can be sec-
ondary and may not have been investigated in detail. In
the androgen receptor C169Y missense mutation, mutant
receptor aggregation causes a change in localization [36].
The wild type protein is in nucleoplasm whereas the
mutant forms aggregate in both nucleus and cytoplasm.
In nine mutations in nonmuscle myosin heavy chain A
(MYH9), the mutant proteins aggregate, causing several
disorders characterized by giant platelets, thrombocytope-
nia, and Döhle body-like cytoplasmic inclusions in gran-
ulocytes [37].
Sometimes localization-changing mutations appear out-
side the targeting signals. Forkhead box (FOX) P2
involved in a speech/language disorder has two separate
nuclear localization signals. Mutant protein R553H is
mainly targeted to the cytoplasm instead of the nucleus
[38]. The mutation appears in the region between but not
within the two nuclear localization signal sequences. Neu-
tral evolution can generate novel targeting signals. Puta-
tive peroxisomal targeting signals were identified from a
number of non-peroxisomal proteins and were shown to
have a potential to be activated if the original target signal
is changed or not accessible [39]. A mutation in the pleck-
strin homology domain of AKT1 kinase leads to cancer
because of pathological localization to the plasma mem-
brane [40]. AKT1 is normally translocated from nucleus to
the plasma membrane in response to growth factor stim-
ulation. A mutant form of E17K, which has increased
phosphorylation, is located at the plasma membrane in
response to growth factor stimulation.
Cell type-specific alternative splicing can alter the localiza-
tion of proteins, including myotonic dystrophy protein
kinase (DMPK) [41]. Still another mechanism affects the
Menkes disease copper ATPase, in which the mutation
G1019D interferes with protein folding [42]. Similar
effects have been seen for certain breast cancer 1 (BRCA1)
mutations [43]. In tafazzin, mutations disrupt the mem-
brane association region [44].
The localization of tyrosine phosphatase SHP-1 is regu-
lated by phosphorylation [45] and alternative start sites
[46,47]. The predictions for mutations in any of these pro-
teins indicated no changes to localization.BMC Genomics 2009, 10:122 http://www.biomedcentral.com/1471-2164/10/122
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Conclusion
Applicability of protein localization prediction methods
were tested in detecting changes in localization due to
point mutations. Altogether 374 mutations were pre-
dicted by at least one method to affect protein localiza-
tion. Because disease mutations are unequally distributed
throughout protein sequences, having a higher occurrence
in structurally/functionally important sites, we can expect
the number of localization mutations to be higher than
calculated. The expected number is 403 mutations. Local-
ization mutations are rare events, but they should be
taken into account when predicting consequences of
mutations. A service for SP predictions will be released in
the near future as part of the Pathogenic-Or-Not -Pipeline
(PON-P, http://bioinf.uta.fi/PON-P).
Methods
Mutation, localization and sequence data
Missense mutations were obtained from the HGMD http:/
/www.hgmd.cf.ac.uk/ac/index.php[48] (downloaded
17.3.2007) and IDbases [12]. The dataset was filtered to
include only genes for which cDNA sequence was availa-
ble. The experimental localization(s) of each identified
protein was collected from the Human Protein Reference
Database (HPRD, http://www.hprd.org/) [3] (4.5.2007).
We excluded proteins for which the experimental localiza-
tion was unknown. After these filtering steps, 1,516 pro-
teins remained, which contained altogether 22,416
missense mutations (on average 14.8 per protein). Alto-
gether, we identified 2,373 localizations, indicating that
the average per-protein localization was ~1.6 for the 1,516
proteins we investigated. The proteins had 34 primary
localizations (Table 1) and altogether 56 localizations
(Additional file 2).
We identified both the first (most common) and all local-
izations for each protein. The wild type protein sequences
were translated from cDNA sequences obtained from
HGMD. The disease-related mutations were introduced
into the protein sequences one by one and analyzed indi-
vidually. Programs and scripts for the analysis were writ-
ten in Java or Perl languages.
Localization prediction methods
First, predictions were made separately for certain locali-
zations and then by two strategies for combined predic-
tions. Groups in Stockholm, Sweden, and Lyngby,
Denmark, whose long-term efforts have resulted in meth-
ods for numerous tasks in subcellular localization predic-
tion, recently published a protocol to combine different
predictions developed by them and others into a compre-
hensive prediction scheme [49]. This Scandinavian proto-
col (SP) is rather complicated and requires the use of
numerous separate prediction tools. To facilitate the anal-
ysis, we developed a program that automatically runs all
the predictions, parses the results, and provides the out-
come of the prediction. The flow chart for the analysis
steps and programs is in Fig 2. As a modification, nuclear
localization signals were predicted only with the Pre-
dictNLS program. Because we analyzed human proteins, it
was not necessary to investigate chloroplast localization
or prokaryotic predictions. Some of the programs use
database searches to identify homologues to strengthen
the predictions. We had to omit this step because the wild
type sequences in the databases are identical to the
mutant sequences, apart from the single missense muta-
tion. Because sequence conservation is indicative of pro-
tein colocalization [50,51], database searches would have
selected the wild type sequence for prediction and thereby
hampered the analysis of mutants. Also the step for β-bar-
rel prediction was omitted.
The programs TargetP [52], SignalP [53] and TMHMM
[54,55] were downloaded from http://www.cbs.dtu.dk/
services/ and were run locally, whereas programs Big-PI
[56-59]http://mendel.imp.ac.at/sat/gpi/gpi_server.html,
NMT http://mendel.imp.ac.at/myristate/SUPLpredic
tor.htm, PeroxiP [60]http://bioinfo.se/PeroxiP/, Pre-
dictNLS [11]http://cubic.bioc.columbia.edu/predictNLS/,
PTS1 [61,62]http://mendel.imp.ac.at/mendeljsp/sat/
pts1/PTS1predictor.jsp, Golgipredictor [63]http://
ccb.imb.uq.edu.au/golgi/, Phobius [64]http://pho
bius.sbc.su.se/ and Prosite [65]http://au.expasy.org/
prosite/ were run over the Internet. Altogether, this proce-
dure could predict 12 different localizations (Fig 1).
In the SP protocol, first the TargetP assigns whether the
proteins go to mitochondia or secretory pathway or not.
The mitochondrial proteins are classified further to trans-
membrane, periplasmic space or matrix based on the
analysis of transmembrane and signal peptide sequences.
Transmembrane proteins are predicted via two routes and
are then classified to those ending in Golgi transmem-
brane or plasma membrane. Signal peptide(s) containing
proteins are classified to different compartments whether
they contain transmembrane region(s), signal peptide, are
myristoylated, have GPI anchors or are predicted to endo-
plasmic reticulum.
The other method we applied, WoLF PSORT, is an inte-
grated program that makes predictions for 10 subcellular
compartments [66]. WoLF PSORT was run locally with
default parameters. WoLF PSORT program was down-
loaded from http://wolfpsort.cbrc.jp/ and run locally.
We ran each prediction strategy for both wild type and
mutated sequences and determined whether the muta-
tion(s) changed the localization prediction. Both proto-
cols may predict multiple localizations for a protein–for
example nucleus and cytosol for a protein that is trans-BMC Genomics 2009, 10:122 http://www.biomedcentral.com/1471-2164/10/122
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ported between nucleus and cytosol. Thus, all highest-
score predictions provided by the programs were taken
into account. In SP, if TargetP had problems to resolve the
localization for a protein predicted to mitochondria with
poor reliability coefficient (RC) (value 4 or 5) then the
protein was predicted also with SignalP and it gets two
alternative localizations (Fig 1).
The two methods predict proteins to following compart-
ments. The SP predicted localization for 12 possible com-
partments, which include the mitochondrial membrane
(transmembrane) (Mtm), mitochondrial periplasmic
space (Mps), mitochondrial matrix (Mma), Golgi, trans-
membrane (Gtm), plasma membrane (PM), secreted (S),
ER lumen (ER), nucleus (N), peroxisome (P), cytoplasmic
C), plasma membrane, GPI anchor (gPM), and plasma
membrane, myristoylated (mPM). WoLF PSORT (animal
version) predicted ten localizations: cytosol (C), cytoskel-
eton (CK), ER, extracellular (S), Golgi apparatus (G), lys-
osome (L), mitochondria (M), nucleus (N), peroxisome
(P) and plasma membrane (PM). All these were present in
the dataset.
The quality of the predictions was measured by four
parameters: accuracy, recall, precision, and the Matthew's
correlation coefficient (MCC) as follows:
where tp is the number of positive cases that were cor-
rectly predicted, tn is the number of negative cases cor-
rectly predicted, fp is the number of positive cases
incorrectly predicted, and the fn is the number of negative
cases incorrectly predicted.
Abbreviations
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